J A P Spijkers-Hagelstein

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants

Emma M. C. Driessen, Eddy H.J. Van Roon, J A P Spijkers-Hagelstein et al. · Haematologica · 2013 · 103 citations · Full text

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

Kirsten Canté-Barrett, J A P Spijkers-Hagelstein, Jessica G. C. A. M. Buijs-Gladdines et al. · Leukemia · 2016 · 89 citations · Full text

Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia

J A P Spijkers-Hagelstein, Pauline Schneider, Esther Hulleman et al. · Leukemia · 2012 · 69 citations

Hematological Malignancy, Lymphoid Neoplasia, Mixed-phenotype Acute Leukemia +9

Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia

J A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider et al. · Leukemia · 2012 · 67 citations

Hematological Malignancy, Signal Transduction, Mixed-phenotype Acute Leukemia +11

Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL

J A P Spijkers-Hagelstein, Sandra S. Pinhanços, Pauline Schneider et al. · Leukemia · 2013 · 37 citations

Genetic Analysis, Allelic Variant, Genetic Disorder +9